Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

0 search results for

Suggestions within Pfizer.com

Press Release Archive

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Careers
Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

April 2024

04.09.2024
- Vaccines
- Vaccines
Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease

March 2024

03.20.2024
- Financial
- Finance
Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts
03.13.2024
- Vaccines
- Vaccines
European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease
03.12.2024
- Medicines
- Research
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
03.05.2024
- Financial
- Finance
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

February 2024

02.29.2024
- Financial
- Investments
Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth
02.29.2024
- Vaccines
- Vaccines
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
02.26.2024
- Financial
- Finance
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
02.19.2024
- Prescription Medicines
- Medicines
European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
02.15.2024
- Financial
- Finance
Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day
02.12.2024
- Corporate
- Partnerships
UT Southwestern collaborates with Pfizer to develop improved RNA Delivery Technologies
02.05.2024
- Prescription Medicines
- Responsibility
Breaking Barriers in Cancer Care: The American Cancer Society and Pfizer Announce a $15 Million, Three-Year Initiative to Bridge the Gap in Cancer Care Disparities

Page 5
Page 6
Current page 7
Page 8
Page 9

Media Resources & Contact Information

Media Contacts
Press Kits

Anyone may view our press releases, press statements, and press kits.

However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Investors
Media
Careers
Partners

Grant Seekers
Healthcare Professionals
Business to Business
Merchandise

Privacy Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube